Loading
Bioceltix S.A. Stock: price and insider trades · Poland
Bioceltix S.A.: what insiders have been doing
Bioceltix S.A., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to KNF. Over the twelve months to 22 October 2026, 2 filings were filed, from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (553 companies, median 3 filings), a count of 2 filings is below the norm.
There has been no open-market purchase by an insider of Bioceltix S.A. for at least a year.
Every figure here comes from the filings published by KNF and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 62.30
Analyst consensus
1 analysts1.00/5
PLN 133.00Target PLN 133.00(+113%)PLN 133.00
Income statement
Gross profit-PLN 2M
EBITDA-PLN 14.3M
Net income-PLN 15.2M0.0% margin
Valuation
PER (forward)-32.8x
P/Book5.5x
Beta0.91
Balance sheet & cash
Market capPLN 344.7M
Total debtPLN 314.9k
Free Cash Flow-PLN 13.9M
Debt / Equity0%
Profitability & ownership
ROE-39.4%
ROA-22.9%
% insiders15.1%
% institutions28.8%
Last declaration on 18 May 2026
Declarations2 total
●
Executives
0KNF
150,000 shares@ PLN 87.00100.0% of flowShareWSEKNF:node/711642
2 of 2 declarations
About Bioceltix S.A.
Bioceltix S.A. is a company specialized in the health and pharmaceutical sector. It is listed on the XWAR market.
